In order to further improve the company’s long-term incentive mechanism,Pro PharmaLimited by Share Ltd (hereinfollowing referred to as “Pro Pharma” or “Company”) recentlyannouncementSaid that the company intends to use a large amount of its own funds to conduct centralized bidding transactionsrepoCompany shares for implementing equity incentive plans or employee stock ownership plans.
The announcement shows that the total repurchase funds are 200 million to 400 million yuan, and the price is not more than 30 yuan per share. According to the upper and lower limits of the repurchase amount, it is estimated that the number of shares that can be repurchased is 6,666,667 shares to 13,333,333 shares, accounting for regarding 0.57% to 1.13% of the company’s total share capital. The repurchase period is within 6 months from the date when the company’s board of directors considers and approves the share repurchase plan.
Regarding the purpose of this share repurchase, the relevant person in charge of the company stated that the company intends to repurchase some of the company’s shares with its own funds on the basis of considering business development prospects, financial conditions, future profitability and the recent performance of the company’s stock secondary market. , used to implement the company’s equity incentive plan or employee stock ownership plan.
(Article source: ShanghaisecuritiesNewspaper Chinasecuritiesnetwork)
Article source: Shanghai Securities News China Securities Network
Responsible editor: 91
Original title: Puluo Pharmaceutical plans to repurchase 200-400 million shares for equity incentives or employee stock ownership plans
Solemnly declare: Oriental Fortune.com releases this information for the purpose of disseminating more information and has nothing to do with the position of this site.
